drugset / Trial / NCT04438655

Prospective Randomized Clinical Trial on Oral and Intravenous Antibiotic Prophylaxis in Colorectal Surgery.

NCT04438655

Completed 130 enrolled University of Turin, Italy
RandomizedParallel-groupOpen-labelPrevention

Summary

Elective colon surgery is considered a clean-contaminated procedure, with a Surgical Site Infection (SSI) rate not inferior to 10%. For many years the role of Mechanical Bowel Preparation (MBP) has been universally recognized as an effective measure to reduce colonic bacterial load and consequently SSI rate, mostly in European Countries. However, in the early 1970s has been demonstrated a further SSI risk reduction in colon surgery if oral non-absorbable antibiotics were added to MBP and for the next 30 years this became the standard of care prior to elective colon surgery, especially in the US. Nowadays, Meta-analyses have demonstrated that MBP does not impact upon postoperative morbidity or mortality, and as such it should not be prescribed routinely. Conversely, recent evidence has suggested that there may be a role for combined MBP and oral antibiotics, or oral antibiotics alone in the prevention of surgical site infection (SSI). The aim of this trial is to evaluate the efficacy of preoperative oral antibiotics prophylaxis for preventing surgical site infections in elective colorectal surgery.

Timeline

Start
2019-05-01
Primary completion
2021-11-01
Completion
2021-11-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bacitracin Unknown 2500 iu Oral
Subject Neomicin Unknown 25000 iu Oral
Background Amoxicillin Other / unclassified 2000 mg Intravenous
Background Clindamycin Unknown 600 mg Intravenous
Background Gentamicin Small molecule 2 mg/kg Intravenous
Background clavulanic acid Small molecule 200 mg Intravenous

Indications

No indication recorded.